APVO icon

Aptevo Therapeutics
APVO

Overview Fund Trends Analyst Outlook Journalist POV

14 hedge funds and large institutions have $89.7M invested in Aptevo Therapeutics in 2021 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 3 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

more funds holding

Funds holding: →

more funds holding in top 10

Funds holding in top 10: →

more ownership

Funds ownership: →

less capital invested

Capital invested by funds: $ → $

67% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 3

Holders
14
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$19.6M
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$1.87M
2
+$928K
3
+$880K

Top Sellers

1
-$2.13M
2
-$1.21M
3
-$999K
4
DTL
Dynamic Technology Lab
Singapore
-$484K
5
BFM
Boothbay Fund Management
New York
-$421K
Name Holding Trade Value Shares
Change 		Change in
Stake
26
$34K
27
$12K
28
$9K
29
$4K
30
$4K
31
$4K
32
$1K
33
–
34
–
35
–
36
–
37
–
38
–
39
–
40
–
41
–
1
2